Evaluation of Napsin A, TTF-1, p63, p40, and CK5/6 Immunohistochemical Stains in Pulmonary Neuroendocrine Tumors

American Journal of Clinical Pathology

Volumn 142, Issue 3, 2014, Pages 320-324

  Zhang, Chen ^a   Schmidt, Lindsay A ^b   Hatanaka, Kazuhito ^c   Thomas, Dafydd ^b   Lagstein, Amir ^b   Myers, Jeffrey L ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Carcinoid; Immunohistochemistry; Napsin A; Pulmonary neuroendocrine tumor

Indexed keywords

NAPSIN A; PROTEIN P40; PROTEIN P63; THYROID TRANSCRIPTION FACTOR 1; TUMOR MARKER; UNCLASSIFIED DRUG; ASPARTIC PROTEINASE; CKAP4 PROTEIN, HUMAN; CYTOKERATIN 5; CYTOKERATIN 6; DNA BINDING PROTEIN; EPITOPE; MEMBRANE PROTEIN; NAPSA PROTEIN, HUMAN; P40, IODINATED C TERMINAL PEPTIDE, HUMAN; P40, IODINATED C-TERMINAL PEPTIDE, HUMAN; PEPTIDE FRAGMENT; TTF1 PROTEIN, HUMAN;

ARTICLE; CARCINOID; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LARGE CELL NEUROENDOCRINE CARCINOMA; LUNG ALVEOLUS MACROPHAGE; LUNG CANCER; LUNG LOBECTOMY; LUNG RESECTION; LUNG TUMOR; NEUROENDOCRINE TUMOR; PULMONARY NEUROENDOCRINE TUMOR; SMALL CELL CARCINOMA; SMALL CELL LUNG CANCER; WEDGE RESECTION; METABOLISM; PATHOLOGY;

CARCINOID; IMMUNOHISTOCHEMISTRY; NAPSIN A; PULMONARY NEUROENDOCRINE TUMOR;

ASPARTIC ACID ENDOPEPTIDASES; DNA-BINDING PROTEINS; HUMANS; IMMUNODOMINANT EPITOPES; IMMUNOHISTOCHEMISTRY; KERATIN-5; KERATIN-6; LUNG NEOPLASMS; MEMBRANE PROTEINS; NEUROENDOCRINE TUMORS; PEPTIDE FRAGMENTS; TUMOR MARKERS, BIOLOGICAL;

EID: 84907168042     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPGA0IUA8BHQEZ     Document Type: Article

References (22)

1. Travis WD. Advances in neuroendocrine lung tumors. Ann Oncol. 2010;21(suppl 7):65-71.
2. Turner BM, Cagle PT, Sainz I M, et al. Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma: evaluation of 1674 cases by tissue microa rray. Arch Pathol Lab Med. 2012;136:163-171.
3. Stoll LM, Johnson MW, Gabrielson E, et al. The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytolo gically poorly differentiated carcinomas. Cancer Cytopathol. 2010;118:441-449.
4. Ueno T, Linder S, Elmberger G. Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma. Br J Cancer. 2003;88:1229-1233.
5. Bishop JA, Sharma R, Illei PB. Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma. Hum Pathol. 2010;41:20-25.
6. A gackiran Y, Ozcan A, Akyurek N, et al. Desmoglein-3 and napsin a double stain, a useful immunohistochemical marker for differentiation of lung squamous cell carcinoma and adenocarcinoma from other subtypes. Appl Immunohistochem Mol M orphol. 2012;20:350-355.
7. Mori K, Kon Y, Konno A, et al. Cellular distribution of napsin (kidney-derived aspartic protease-like protein, KAP) mRNA in the kidney, lung and lymphatic organs of adult a nd developing mice. Arch Histol Cytol. 2001;64:319-327.
8. Stahlman MT, Gray ME, Whitsett JA. Expression of thyroid transcription factor-1(TTF-1) in fetal and neonatal human lung. J Histochem Cytochem. 1996;44:673-678.
9. Srivastava A,Hornick JL. Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pul monary carcinoid tumors Am J Surg Pathol. 2009 33, 626-632.
10. Wang BY, Gil J, Kaufman D, et al. P63 in pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumors. Hum Pathol. 2002;33:921-926.
11. Tatnell PJ, Powell DJ, Hill J, et al. Napsins: new human aspartic proteinases. Distinction between two closely related genes. FEBS Lett. 1998;441:43-48.
12. Hirano T, Auer G, Maeda M, et al. Human tissue distribution of TA02, which is homologous with a new type of aspartic proteinase, napsin A. Jpn J Cancer Res. 2000;91:1015-1021.
13. Chuman Y, Bergman A, Ueno T, et al. Napsin A, a member of the aspartic protease family, is abundantly expressed in normal lung and kidney tissue and is expressed in lung adenocarcinomas. FEBS Lett. 1999;462:12 9-134.
14. Schmidt LA, Myers JL, McHugh JB. Napsin A is differentially expressed in sclerosing hemangiomas of the lung. Arch Pathol Lab Med. 2012;136:1580-1584.
15. Morita S, Yoshida A, Goto A, et al. High-grade lung adenocarcinoma with fetal lung-like morphology: clinicopathologic, immunohistochemical, and molecular analyses of 17 cases. Am J Surg Pathol. 2013;37:924-932.
16. Folpe AL, Gown AM, Lamps LW, et al. Thyroid transcription factor-1: immunohistochemical evaluation in pulmonary neuroendocrine tumors. Mod Pathol. 1999;12:5-8.
17. Sturm N, Rossi G , Lantuejoul S, et al. Expression of thyroid transcription factor-1 in the spectrum of neuroendocrine cell lung proliferations with special interest in carcinoids. Hum Pathol. 2002;33:175-182.
18. Tsuta K, Kalhor N, Wistuba II, et al. Clinicopathological and immunohistochemical analysis of spindle-cell carcinoid tumour of the lung. Histopathology. 2011;59:526-536.
19. Warth A, Muley T, Herpel E, et al. Large-scale comparative analyses of immunomarkers for diagnostic subtyping of non-small-cell lung cancer biopsies. Histopathology. 2012;61:1017-1025.
20. Bishop JA, Teruya-Feldstein J, Westra WH, et al. p40 (DeltaNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma. Mod Pathol. 2012;25:405-415.
21. Pelosi G, Rossi G, Cavazza A, et al. DeltaNp63 (p40) distribution inside lung cancer: a driver biomarker approach to tumor characterization. Int J Surg Pathol. 2013;21:229-239.
22. Butnor KJ, Burchette JL. p40 (DeltaNp63) and keratin 34betaE12 provide greater diagnostic accuracy than p63 in the evaluation of small cell lung carcinoma in small biopsy samples. Hum Pathol. 2013;44:1497-1486.